Prodromal PD – Fact or fiction?

“While the diagnosis of Parkinson’s disease (PD) remains focused on motor symptoms, the underlying pathological process clearly starts many years before these overt signs” began Dr Alastair Noyce (Queen Mary University London). In this ‘prediagnostic’ phase, a diverse range of non-motor and motor features can occur with a wealth of evidence now [...]

Continue Reading »

How can we target the disease mechanisms in Parkinson’s disease?

“There is currently a great deal of research being conducted on Parkinson’s disease. The Cure Parkinson’s Trust is involved in 17 trials and patients are desperate for information” stated Dr Simon Stott of The Cure Parkinson’s Trust. PD is a multifactorial disease, where both genetic and environmental factors are involved, and this provides a smorgasbord [...]

Continue Reading »

Non-pharmacological therapies: An evidence free zone?

Current medical management is only partially effective in controlling the symptoms and signs of Parkinson’s disease (PD). Medication mainly targets impairments related to dopaminergic lesions and is, therefore, not effective for symptoms that are largely related to non-dopaminergic lesions, such as impaired balance or dementia. Consequently, even with [...]

Continue Reading »

Double Dutch – Case presentation by Prof Bas Bloem

Using a series of cases, Professor Bastiaan Bloem (Director, Parkinson Center, Nijmegen, The Netherlands) underscored the importance of clinical observation in his daily practice. The first case was of a professional violinist whose tremor resulted in him retiring from his passion.1 Professor Bloem explained that this patient typically increased his [...]

Continue Reading »

Has Parkinson’s treatment really changed?

Back in June the Parkinson’s Academy hosted “Cutting Edge Science for Parkinson’s Clinicians”, an educational meeting sponsored by Bial Pharma. Now in its second year the meeting was a sell-out again and expectations were high. Chaired by Dr Peter Fletcher (Gloucestershire Hospitals NHS Foundation Trust), the meeting was designed to cater to the diverse needs […]

Continue Reading »

Now open for registration: Cutting Edge Science for Parkinson’s Clinicians 2019

In July 2018 the Parkinson’s Academy hosted a meeting, sponsored by Bial Pharma UK Ltd in Birmingham. ‘Cutting Edge Science for Parkinson’s Clinicians’ was designed to advance scientific insights for specialists working within Parkinson’s disease. Follow-up meeting: 25 & 26 June 2019 Macdonald Burlington Hotel, Birmingham, B2 4JQ   We are currently planning a follow-up […]

Continue Reading »

Cutting Edge Science – Where are we with deep brain stimulation?

In July this year, the Parkinson’s Academy presented “Cutting Edge Science for Parkinson’s Clinicians”, an educational meeting sponsored by Bial Pharma UK Ltd. This one-day meeting was chaired by Dr Peter Fletcher and attended by a diverse audience of neurologists, care of the elderly physicians, psychiatrists and Parkinson’s nurses. The meeting was a chance to […]

Continue Reading »

Cutting Edge Science – Is postural instability the clinical cornerstone of Parkinson’s diagnosis?

In July this year, the Parkinson’s Academy presented “Cutting Edge Science for Parkinson’s Clinicians”, an educational meeting sponsored by Bial Pharma UK Ltd. This one-day meeting was chaired by Dr Peter Fletcher and attended by a diverse audience of neurologists, care of the elderly physicians, psychiatrists and Parkinson’s nurses. The meeting was a chance to […]

Continue Reading »

Cutting Edge Science – Personalised medicine in Parkinson’s: From theory to reality

In July this year, the Parkinson’s Academy presented “Cutting Edge Science for Parkinson’s Clinicians”, an educational meeting sponsored by Bial Pharma UK Ltd. This one-day meeting was chaired by Dr Peter Fletcher and attended by a diverse audience of neurologists, care of the elderly physicians, psychiatrists and Parkinson’s nurses. The meeting was a chance to […]

Continue Reading »

Cutting Edge Science – Where are we going with medications?

In July this year, the Parkinson’s Academy presented “Cutting Edge Science for Parkinson’s Clinicians”, an educational meeting sponsored by Bial Pharma UK Ltd. This one-day meeting was chaired by Dr Peter Fletcher and attended by a diverse audience of neurologists, care of the elderly physicians, psychiatrists and Parkinson’s nurses. The meeting was a chance to […]

Continue Reading »